There is a need to have a global multilateral approach to deal with Covid pandemic: Nirmala Sitharaman
New Delhi:
Stressing that there cannot be any vaccine nationalism, Finance Minister Nirmala Sitharaman on Monday urged nations to share technologies on COVID vaccines amid the pandemic.
She also pitched for examining Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement in the light of the coronavirus pandemic. Countries will have to be open about sharing vaccine-based technologies. The TRIPS agreement will have to be looked at in the context of the pandemic. There cannot be any more vaccine nationalism, countries will have to be flexible about it, she said at the annual meet of the Asian Development Bank (ADB).
Countries must share vaccine tech; no space for vaccine nationalism : Nirmala Sitharaman Countries will have to be open about sharing vaccine-based technologies. The TRIPS agreement will have to be looked at in the context of the pandemic, said Nirmala Sitharaman
BusinessToday.In | May 3, 2021 | Updated 18:02 IST
Nirmala Sitharaman says no space for vaccine nationalism
Finance Minister Nirmala Sitharaman said on Monday that countries must share vaccine-based technologies with each other. The FM said that there is no space for vaccine nationalism. She also said that the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement must be looked at amid the ravaging coronavirus pandemic.
US Noncommittal on Vaccine Patents Waiver
Voice of America
03 May 2021, 22:05 GMT+10
WASHINGTON - Amid a surge of COVID-19 cases in India and other parts of the world, the United States remains noncommittal on an October 2020 proposal by India and South Africa to waive certain provisions of the World Trade Organization s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
The proposal would loosen patent restrictions so that countries can manufacture generic versions of the coronavirus vaccines. We are working with our global partners to explore pragmatic and effective steps to surge production and equitable distribution of vaccines, a United States Trade Representative (USTR) official told VOA.